Penn Pharma Installs new Gerteis Roller Compactor Technology
Pharmaceutical manufacturer Penn Pharma has successfully installed a Gerteis Mini-Pactor at its contained manufacturing facility. This investment in new contained roller compaction technology will further expand its service offering at the award winning site in South Wales.
Penn Pharma, a PCI company, was proud to show off the installation of the new Mini-Pactor, which was successfully and safely maneuvered through a customised roof into the state-of-the-art contained manufacturing facility.
The Mini-Pactor was elevated and placed into position through the recently redesigned purpose-built flexible roof, fitted to allow the safe installation of this latest important technology.
Roller compaction is a process that provides a granulation method for materials that are heat and moisture sensitive, avoiding the use of liquid and high temperatures associated with wet granulation and subsequent drying methods. The Gerteis Mini-Pactor offers a patented, proven design that enhances powder flow as well as effective containment using skan isolator technology and integrated cleaning systems. The process is easily scaleable, facilitating shorter and less costly development programmes.
Bill Mitchell, CEO of parent company PCI, which acquired Penn in August 2014, was on site to oversee this latest milestone. Bill commented: “This latest investment is a further demonstration to our customers of the commitment we have made to deliver best in class solutions. This contained roller compactor increases our ability to provide advanced services in response to growing market demand for the processing and manufacturing of solid dosage forms containing potent molecules.
“The PCI Penn Tredegar site has more than 20 years of experience in the use of roller compactor technology. By combining expertise gained over time with state of the art technology, we understand the importance of this technology and its application in addressing the specific needs of our customers.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance